Scientific Music Medicine

Your Shopping Cart  Shopping Cart

Home   Site Map    Research    Reports    Intern. Experts    Music Preparations    Fundamentals    Store    Contact
peter hübner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields in Detail

Hormone System

High Hormone Levels

Low Hormone Levels

Kariopicnotic Index

Hormone Status

Hormone Status

 

 






Improvement of the Hormone Status in Pregnant Women with Somatic Disorders in the Last Month of Pregnancy



The pregnant women were sent to hospital, because the fetuses were in danger due to rheumatism and heart, kidney and liver prob­lems of the mothers. All women received a conventional medical drug therapy as well as a treatment with physiotherapeutic exercises.

Information about the well being of the fetus was derived by the levels of placenta-lac­to­gen in blood plasma as well of estriol in the urine of the mother. These hormone levels were measured before starting with the treat­ment and at the end of the treatment.


Medical Resonance Therapy Music® Group

In addition to the conventional drug therapy 15 women listened after physiotherapeutic ex­er­cises for seven days one hour to relaxing music preparations of Medical Resonance Therapy Music® via cd-player and headphone.

Together with the conventional treatment the Medical Resonance Therapy Music® improved the hormone status very clearly:
the level of placenta-lactogen rose from 217.5 nmol/l (± 5.3) to 274.9 nmol/l (± 5.7) and the estriol level from 80.0 µmol/24 hours (±2) to 103.3 µmol/24 hours (±1.7), which clearly demonstrates a positive effect of the Medical Resonance Therapy Music® on the function of the fetal-placental unit and through this on the well-being of the pregnant woman and her fetus.
Control Group


In this group 10 pregnant women received the conventional treatment only.

The hormone levels changed merely: pla­cen­ta­lac­to­gen went down from 203.9 nmol/l (±3,6) before the treatment to 203.5 nmol/l (±5.1) after ending the therapy, and parallel to this estriol dropped from 77.1 µmol/24 hours (±1.8) to 75.8 µmol/24 hours (±2). Here the conventional treatment alone did not create an increase in the well-being of the pregnant and her fetus.










 

Investigators:

Prof. Dr. med. A. Reznikov
Dr. med. I. Stepanenko
Dr. med. D. Sutkovoy




With kind permission of AAR EDITION INTERNATIONAL
© 1998- SCIENTIFIC MUSIC MEDICINE | Contact

Subject to change in the interests of scientific advancement.